VREXNasdaqElectronic Components, NECUS GAAP · USD

Varex Imaging Corp

Varex Imaging Corp designs and manufactures X-ray imaging components and related systems used inside medical, security, and industrial inspection equipment. Its portfolio includes X-ray tubes, flat panel and photon counting detectors, high-voltage connectors, image-processing software, linear accelerators, and select stand-alone X-ray systems, with engineering, manufacturing, and service operations across North America, Europe, and Asia.

Liikevaihto845milj. USD
+4,1 %v/v
Liikevoitto (EBIT)−27,8milj. USD
−186,6 %v/v
EBIT-marginaali−3,3%
−7,2 %-yks.v/v
Nettotulos−70,3milj. USD
−44,1 %v/v
Vapaa kassavirta18,8milj. USD
−7,8 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

−20002004006008001 000milj. USD2020: 738 milj. USD2020: EBIT −34 milj. USD20202021: 818 milj. USD2021: EBIT 74 milj. USD20212022: 859 milj. USD2022: EBIT 88 milj. USD20222023: 893 milj. USD2023: EBIT 77 milj. USD20232024: 811 milj. USD2024: EBIT 32 milj. USD20242025: 845 milj. USD2025: EBIT −28 milj. USD2025845−28
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Medical imaging components60 %

X-ray tubes, detectors, and related parts used in diagnostic imaging equipment.

Security inspection components15 %

X-ray sources and detectors used in security screening and inspection systems.

Industrial inspection components15 %

X-ray products used for non-destructive testing and quality inspection in manufacturing.

Software and accessories10 %

Image-processing software, connectors, and other supporting products sold with hardware.

Asiakkaat

Varex sells primarily to original equipment manufacturers that design its components into finished X-ray systems. Its customer base also includes system integrators, independent service companies, distributors, and some end users buying replacement parts. Demand is driven by medical imaging OEMs, security screening vendors, and industrial manufacturers that need specialized X-ray performance, reliability, and regulatory continuity.

Medical imaging OEMs

Buy X-ray tubes, detectors, and related components for CT, radiography, and other diagnostic systems; they value performance, reliability, and long-term supply.

Security inspection OEMs

Buy X-ray sources and detectors for screening systems used in airports, borders, and cargo inspection.

Industrial inspection OEMs and integrators

Buy components for non-destructive testing, defect detection, and measurement applications in manufacturing.

Replacement and service market

Buy spare parts, service components, and support products for installed X-ray systems over long equipment lives.

Strategia

Varex’s strategy centers on maintaining technology leadership in X-ray components through ongoing R&D, product performance improvements, and close collaboration with OEM customers. It also relies on manufacturing scale and long customer relationships to keep its components designed into installed systems and replacement channels. Growth opportunities are tied to new detector technologies, photon counting, and broader adoption of X-ray inspection in industrial applications.

Advance detector and tube technologyKeskipitkä aikaväli

New imaging performance helps win OEM design-ins and defend against in-house competition.

Grow industrial non-destructive testing applicationsKeskipitkä aikaväli

Industrial inspection broadens end markets beyond medical imaging and supports new use cases.

Protect OEM design-in relationshipsLyhyt aikaväli

Once components are integrated into customer systems, switching costs and regulatory approvals support recurring demand.

Maantiede

Q2/2026

Varex sells into three reporting regions: the Americas, EMEA, and APAC, with final destination of products determining revenue geography. Its engineering, manufacturing, and service sites are spread across North America, Europe, and Asia, which supports proximity to OEM customers and global supply chains. The business is exposed to trade policy, import/export rules, and cross-border logistics because components and finished systems move through multiple jurisdictions.

Americas18 %
Asia Pacific18 %
USA16 %
Other countries (US filing)16 %
EMEA14 %
Japan9,7 %
Kina7,7 %

Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.

Riskit

Varex is exposed to customer concentration, since a small number of OEMs account for a large share of revenue and many customers also compete with it. The business also faces trade-policy, tariff, and export-control risk because it operates globally and ships components across borders, while product defects, regulatory issues, and goodwill impairment can affect results and reported assets.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Customer concentration and OEM dependency1Trade and tariff disruption2China regulatory and policy risk3Goodwill impairment4Product liability and quality failure5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Customer concentration and OEM dependencyVaikutus: KorkeaTodennäköisyys: Korkea

    A limited number of large OEMs account for a substantial share of revenue, so order delays or losses can quickly reduce sales.

    KohdistuuCanonUnited Imaging HealthcareGESiemensRapiscan
  2. Trade and tariff disruptionVaikutus: KorkeaTodennäköisyys: Korkea

    The company manufactures and sells across regions, so import/export restrictions and tariffs can raise costs or block shipments.

    KohdistuuAmericasEMEAAPAC
  3. China regulatory and policy riskVaikutus: KorkeaTodennäköisyys: Korkea

    Medical products imported into China may be affected by investigations or policy changes, creating demand and compliance uncertainty.

    Kohdistuu: China

  4. Goodwill impairmentVaikutus: KorkeaTodennäköisyys: Korkea

    Acquired goodwill is tested for impairment and can be written down if forecasts, market value, or segment performance weaken.

  5. Product liability and quality failureVaikutus: KeskitasoTodennäköisyys: Korkea

    X-ray components are embedded in regulated systems, so defects can lead to recalls, claims, or reputational damage.

Kirjanpito

Harkinnanvaraiset erät
Inventory valuation

Components are specialized and demand can shift, so management must estimate excess and obsolete inventory reserves.

Vaikutus: Cost of revenues and gross margin

Goodwill impairment

The Medical reporting unit was impaired after lower forecasts and market-cap declines, showing sensitivity to assumptions.

Vaikutus: Large non-cash operating charge

Intangible assets

Acquired technologies and customer relationships are amortized and may be impaired if expected cash flows weaken.

Vaikutus: Operating income and asset values

Income taxes

Global operations create multi-jurisdiction tax estimates and potential valuation allowance judgments.

Vaikutus: Tax expense and effective tax rate

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026

Varex Imaging Corp (VREX) liikevaihto, tulos ja tunnusluvut 2025 – Clarifo